SCHEMBL910050

SCHEMBL910050

CC(C)CN.CC(C)CNC(=O)O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.81
CYP2D6 P10635 1/20 0.81
MMP1 P03956 2/20 0.45
MMP8 P22894 2/20 0.45
MAPT P10636 2/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
HPGD P15428 4/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
CACNA2D1 P54289 2/20 0.39
CACNB3 P54284 1/20 0.39
CACNA1C Q13936 1/20 0.39
PGR P06401 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR2B P41595 1/20 0.39
CACNA2D2 Q9NY47 1/20 0.39
EPHX1 P07099 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropylamine SCHEMBL3793495 0.96 CYP2C19 (0.74) CYP2C19CYP2D6MMP1MMP8MAPT
Isopropylamine SCHEMBL3793497 0.96 CYP2C19 (0.74) CYP2C19CYP2D6MMP1MMP8MAPT
SCHEMBL402167 0.90
SCHEMBL14801544 0.81
SCHEMBL28518601 0.81
SCHEMBL29240481 0.81
SCHEMBL11174303 0.79 CYP2D6 (0.50) CYP2C19CYP2D6MMP1MMP8MAPT
SCHEMBL6576548 0.77 CYP2C19 (0.74) CYP2C19CYP2D6MMP1MMP8MAPT
SCHEMBL11174308 0.76 CYP2C19 (0.46) CYP2C19CYP2D6MMP1MMP8MAPT
Bicarbonate SCHEMBL25298921 0.76 CACNA2D1 (0.50) CYP2C19CYP2D6ALDH1A1CACNA2D1CACNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10799443-B2 Crosslinkable coating compositions formulated with dormant carbamate initiator ELEMENTIS SPECIALTIES, INC. (US) 2020-10-13 US claimed
US-20200214966-A1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR ELEMENTIS SPECIALTIES, INC. (US) 2020-07-09 US claimed
EP-3284792-B1 METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME INKTEC CO LTD (KR) 2019-10-09 EP claimed
EP-2066497-B1 MANUFACTURING METHODS FOR METAL CLAD LAMINATES INKTEC CO LTD (KR) 2018-11-07 EP claimed
EP-2013298-B1 COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME INKTEC CO LTD (KR) 2018-06-27 EP claimed
EP-3284792-A1 METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME Inktec Co., Ltd. (KR) 2018-02-21 EP claimed
US-9786843-B2 Methods for fabricating an optoelectronic device INKTEC CO., LTD. (KR) 2017-10-10 US claimed
US-9556065-B2 Transparent conductive layer and preparation method thereof INKTEC CO., LTD. (KR) 2017-01-31 US claimed
EP-2003976-B1 USE OF AN ANTIBACTERIAL COMPOSITION CONTAINING ORGANIC SILVER COMPLEXES INKTEC CO LTD (KR) 2016-12-21 EP claimed
EP-2052043-B1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO LTD (KR) 2016-10-12 EP claimed
US-20080206488-A1 Conductive Inks and Manufacturing Method Thereof INKTEC CO., LTD. (KR) 2008-08-28 US claimed
WO-2008018718-A1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO., LTD. (KR) 2008-02-14 WO claimed
WO-2008018719-A1 MANUFACTURING METHODS FOR METAL CLAD LAMINATES INKTEC CO., LTD. (KR) 2008-02-14 WO claimed
CN-101107257-A Organic silver complex, method for producing same, and method for forming thin layer using same INKTEC CO LTD (KR) 2008-01-16 CN claimed
WO-2007126277-A1 ALUMINUM WHEEL HAVING HIGH GLOSS INKTEC CO., LTD. (KR) 2007-11-08 WO claimed
WO-2007126276-A1 COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME INKTEC CO., LTD. (KR) 2007-11-08 WO claimed
EP-1846422-A1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS Inktec Co., Ltd. (KR) 2007-10-24 EP claimed
WO-2007105912-A1 ANTIBACTERIAL COMPOSITION CONTAINING ORGANIC SILVER COMPLEXES, ANTIBACTERIAL TREATMENT METHODS USING THE SAME AND ANTIBACTERIAL FORMED ARTICLE INKTEC CO., LTD. (KR) 2007-09-20 WO claimed
WO-2006107176-A1 ETCHING SOLUTIONS INKTEC CO., LTD. (KR) 2006-10-12 WO claimed
WO-2006083153-A1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO., LTD. (KR) 2006-08-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200214966-A1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR ETF1, CECR2, H1-2 CYP2C19 625/4885CYP2D6 2699/4885MMP1 2555/4885
US-10799443-B2 Crosslinkable coating compositions formulated with dormant carbamate initiator ETF1, CECR2, H1-2 CYP2C19 625/4885CYP2D6 2699/4885MMP1 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.